Single antiplatelet therapy after percutaneous coronary intervention in patients allergic to aspirin

Leon, 1998, A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent anticoagulation restenosis study investigators, N Engl J Med, 339, 1665, 10.1056/NEJM199812033392303 Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4 Hahn, 2010, Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (duration of dual antiplatelet therapy after implantation of endeavor stent) registry, Circ J, 74, 2314, 10.1253/circj.CJ-10-0347 Kim, 2012, A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (Real safety and efficacy of 3-month dual antiplatelet therapy following endeavor zotarolimus-eluting stent implantation), J Am Coll Cardiol, 60, 1340, 10.1016/j.jacc.2012.06.043 Steinhubl, 2009, Aspirin following PCI: too much of a good thing?, Eur Heart J, 30, 882, 10.1093/eurheartj/ehp105 Cleland, 2013, Is aspirin useful in primary prevention?, Eur Heart J, 34, 3412, 10.1093/eurheartj/eht287 Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746 Ndrepepa, 2008, Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point, J Am Coll Cardiol, 51, 690, 10.1016/j.jacc.2007.10.040 Derry, 2000, Risk of gastrointestinal haemorrhage with long term use of aspirin: a meta-analysis, BMJ, 321, 1183, 10.1136/bmj.321.7270.1183 Newby, 2003, Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation, J Thromb Thrombolysis, 16, 119, 10.1023/B:THRO.0000024050.78728.35 Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989 Schwartz, 1988, Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty, N Engl J Med, 318, 1714, 10.1056/NEJM198806303182603 Savage, 1995, Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-hospital eastern Atlantic restenosis trial (M-HEART II), Circulation, 92, 3194, 10.1161/01.CIR.92.11.3194 Diener, 2004, Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial, Lancet, 364, 331, 10.1016/S0140-6736(04)16721-4 Eisenberg, 2009, Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents, Circulation, 119, 1634, 10.1161/CIRCULATIONAHA.108.813667 Stone, 2013, Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study, Lancet, 382, 614, 10.1016/S0140-6736(13)61170-8 Van Werkum, 2009, Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry, J Am Coll Cardiol, 53, 1399, 10.1016/j.jacc.2008.12.055 Storey, 2010, Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (platelet inhibition and patient outcomes) PLATELET substudy, J Am Coll Cardiol, 56, 1456, 10.1016/j.jacc.2010.03.100 Patti, 2011, High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation, J Am Coll Cardiol, 57, 771, 10.1016/j.jacc.2010.09.050 Mehta, 2010, Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial, Lancet, 376, 1233, 10.1016/S0140-6736(10)61088-4 Price, 2011, Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention. The GRAVITAS randomized trial., JAMA, 305, 1097, 10.1001/jama.2011.290 Parodi, 2011, High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI, JAMA, 306, 1215, 10.1001/jama.2011.1332 Palmerini, 2013, Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis, J Am Coll Cardiol, 62, 496, 10.1016/j.jacc.2013.05.022 Cassese, 2013, Antiplatelet therapy after genous EPC-capturing coronary stent implantation: the ARGENTO Study: a prospective, multicenter registry, Int J Cardiol, 167, 757, 10.1016/j.ijcard.2012.03.052 Kim, 2009, Evaluation in 3months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial, J Am Coll Cardiol Intv, 2, 1240, 10.1016/j.jcin.2009.10.006 Matsumoto, 2007, Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography, Eur Heart J, 28, 961, 10.1093/eurheartj/ehl413 Dewilde, 2013, Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial, Lancet, 381, 1107, 10.1016/S0140-6736(12)62177-1 Ramanuja, 2004, Approach to “aspirin allergy” in cardiovascular patients, Circulation, 110, e1, 10.1161/01.CIR.0000134306.28561.2A Angiolillo, 2008, A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study, Eur Heart J, 29, 2202, 10.1093/eurheartj/ehn287